Loading viewer...
earnings
Format: PDF earnings
Natera's Q3 2022 earnings presentation reports $210.6M in total revenue with 33% YoY growth and 518K tests processed. The company highlighted strong momentum in oncology testing with 53K Signatera tests (150%+ YoY growth) and expanded reimbursement coverage, while announcing updated full-year revenue guidance of $810M-$830M.
earnings
21 Pages
earnings
32 Pages
Teradata
Nikola Corporation Q3 2023 Earnings Presentation
earningsearnings
17 Pages
Nikola Corporation
Westlake Corporation Q2 2023 Earnings Presentation
earningsearnings
16 Pages
Westlake Corporation